{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:07:37Z","timestamp":1790813257359,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009057","name":"Associazione Italiana per la Lotta al Neuroblastoma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.coph.2019.03.003","type":"journal-article","created":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T21:47:34Z","timestamp":1556401654000},"page":"24-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"special_numbering":"C","title":["Phylogenies in ART: HIV reservoirs, HIV latency and drug resistance"],"prefix":"10.1016","volume":"48","author":[{"given":"Alessandra","family":"Bandera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Sironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2019.03.003_bib0005","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1073\/pnas.94.24.13193","article-title":"Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy","volume":"94","author":"Chun","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2019.03.003_bib0010","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.coph.2019.03.003_bib0015","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1126\/science.278.5341.1291","article-title":"Recovery of replication-competent HIV despite prolonged suppression of plasma viremia","volume":"278","author":"Wong","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.coph.2019.03.003_bib0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ebiom.2016.07.024","article-title":"HIV DNA set point is rapidly established in acute hiv infection and dramatically reduced by early ART","volume":"11","author":"Ananworanich","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coph.2019.03.003_bib0025","doi-asserted-by":"crossref","first-page":"8869","DOI":"10.1073\/pnas.95.15.8869","article-title":"Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection","volume":"95","author":"Chun","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2019.03.003_sbref0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002417","article-title":"HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study","volume":"14","author":"Henrich","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.coph.2019.03.003_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003211","article-title":"Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study","volume":"9","author":"Saez-Cirion","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coph.2019.03.003_bib0040","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm.1972","article-title":"HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation","volume":"15","author":"Chomont","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2019.03.003_bib0045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nm.3445","article-title":"HIV-1 persistence in CD4+ T cells with stem cell-like properties","volume":"20","author":"Buzon","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2019.03.003_bib0050","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nm.3781","article-title":"B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers","volume":"21","author":"Fukazawa","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2019.03.003_bib0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17057-y","article-title":"Peripheral T follicular helper cells make a difference in HIV reservoir size between Elite controllers and patients on successful cART","volume":"7","author":"Garcia","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2019.03.003_bib0060","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1128\/JVI.76.2.707-716.2002","article-title":"Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy","volume":"76","author":"Zhu","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.coph.2019.03.003_bib0065","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1016\/j.celrep.2018.11.104","article-title":"Hematopoietic stem and progenitor cells are a distinct HIV reservoir that contributes to persistent viremia in suppressed patients","volume":"25","author":"Zaikos","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.coph.2019.03.003_bib0070","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1097\/QAD.0b013e3282efb74b","article-title":"The intestinal mucosa as a reservoir of HIV-1 infection after successful HAART","volume":"21","author":"Belmonte","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.coph.2019.03.003_sbref0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nature16933","article-title":"Persistent HIV-1 replication maintains the tissue reservoir during therapy","volume":"530","author":"Lorenzo-Redondo","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.coph.2019.03.003_bib0080","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01186-17","article-title":"Brain macrophages in simian immunodeficiency virus-infected, antiretroviral-suppressed macaques: a functional latent reservoir","volume":"8","author":"Avalos","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.coph.2019.03.003_bib0085","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1128\/JVI.00290-16","article-title":"Quantitation of productively infected monocytes and macrophages of simian immunodeficiency virus-infected macaques","volume":"90","author":"Avalos","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.coph.2019.03.003_bib0090","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1097\/QAD.0000000000000400","article-title":"Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation","volume":"28","author":"Dahl","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.coph.2019.03.003_bib0095","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/cid\/cit195","article-title":"Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy","volume":"57","author":"Fiscus","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coph.2019.03.003_bib0100","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11904-018-0378-z","article-title":"HIV persistence in adipose tissue reservoirs","volume":"15","author":"Couturier","year":"2018","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.coph.2019.03.003_bib0105","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1016\/S2352-3018(18)30039-0","article-title":"Barriers and strategies to achieve a cure for HIV","volume":"5","author":"Pitman","year":"2018","journal-title":"Lancet HIV"},{"key":"10.1016\/j.coph.2019.03.003_sbref0110","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1172\/JCI94582","article-title":"No evidence of HIV replication in children on antiretroviral therapy","volume":"127","author":"Van Zyl","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coph.2019.03.003_bib0115","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx173","article-title":"Ongoing HIV replication during ART reconsidered","volume":"4","author":"Kearney","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.coph.2019.03.003_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004010","article-title":"Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy","volume":"10","author":"Kearney","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coph.2019.03.003_sbref0125","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18889","article-title":"Establishment and stability of the latent HIV-1 DNA reservoir","volume":"5","author":"Brodin","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.coph.2019.03.003_bib0130","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01589-17","article-title":"Size, composition, and evolution of HIV DNA populations during early antiretroviral therapy and intensification with maraviroc","volume":"92","author":"Chaillon","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.coph.2019.03.003_bib0135","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1038\/nature24634","article-title":"Re-evaluating evolution in the HIV reservoir","volume":"551","author":"Rosenbloom","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.coph.2019.03.003_bib0140","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1093\/jac\/dku147","article-title":"Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy","volume":"69","author":"Raymond","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.coph.2019.03.003_bib0145","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1073\/pnas.1318249111","article-title":"Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues","volume":"111","author":"Fletcher","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2019.03.003_bib0150","doi-asserted-by":"crossref","first-page":"8984","DOI":"10.1128\/JVI.00684-16","article-title":"HIV maintains an evolving and dispersed population in multiple tissues during suppressive combined antiretroviral therapy in individuals with cancer","volume":"90","author":"Rose","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.coph.2019.03.003_bib0155","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nm.2111","article-title":"HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects","volume":"16","author":"Buzon","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2019.03.003_bib0160","doi-asserted-by":"crossref","first-page":"E4987","DOI":"10.1073\/pnas.1308313110","article-title":"The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time","volume":"110","author":"Josefsson","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2019.03.003_bib0165","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/infdis\/jiv092","article-title":"Longitudinal genetic characterization reveals that cell proliferation maintains a persistent HIV Type 1 DNA pool during effective HIV therapy","volume":"212","author":"von Stockenstrom","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coph.2019.03.003_bib0170","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1084\/jem.20170193","article-title":"Proliferation of latently infected CD4(+) T cells carrying replication-competent HIV-1: potential role in latent reservoir dynamics","volume":"214","author":"Hosmane","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.coph.2019.03.003_bib0175","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1172\/JCI93289","article-title":"Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cells","volume":"127","author":"Lee","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coph.2019.03.003_sbref0180","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41591-018-0017-7","article-title":"Clonal CD4(+) T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation","volume":"24","author":"Cohn","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2019.03.003_bib0185","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.celrep.2017.09.081","article-title":"Identification of genetically intact HIV-1 proviruses in specific CD4(+) T cells from effectively treated participants","volume":"21","author":"Hiener","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.coph.2019.03.003_bib0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006283","article-title":"Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir","volume":"13","author":"Bui","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coph.2019.03.003_bib0195","first-page":"E2575","article-title":"Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane","volume":"115","author":"Wang","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2019.03.003_bib0200","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.cell.2016.06.039","article-title":"Multiple origins of virus persistence during natural control of HIV infection","volume":"166","author":"Boritz","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.coph.2019.03.003_bib0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002506","article-title":"Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection","volume":"8","author":"Evering","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coph.2019.03.003_sbref0210","doi-asserted-by":"crossref","first-page":"e588","DOI":"10.1016\/S2352-3018(18)30173-5","article-title":"HIV drug resistance in low-income and middle-income countries","volume":"5","author":"Hamers","year":"2018","journal-title":"Lancet HIV"},{"key":"10.1016\/j.coph.2019.03.003_sbref0215","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/vex008","article-title":"Transmission fitness of drug-resistant HIV revealed in a surveillance system transmission network","volume":"3","author":"Wertheim","year":"2017","journal-title":"Virus Evol"},{"key":"10.1016\/j.coph.2019.03.003_bib0220","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cit694","article-title":"Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study","volume":"58","author":"Drescher","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coph.2019.03.003_bib0225","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/QAD.0000000000000768","article-title":"A phylotype-based analysis highlights the role of drug-naive HIV-positive individuals in the transmission of antiretroviral resistance in the UK","volume":"29","author":"Mourad","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.coph.2019.03.003_bib0230","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/cid\/civ393","article-title":"Evidence of self-sustaining drug resistant HIV-1 lineages among untreated patients in the United Kingdom","volume":"61","author":"Mbisa","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coph.2019.03.003_bib0235","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12977-014-0105-9","article-title":"Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity","volume":"11","author":"Pingen","year":"2014","journal-title":"Retrovirology"},{"key":"10.1016\/j.coph.2019.03.003_bib0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004722","article-title":"Persistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgrounds","volume":"11","author":"Yang","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coph.2019.03.003_sbref0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006895","article-title":"Quantifying the fitness cost of HIV-1 drug resistance mutations through phylodynamics","volume":"14","author":"Kuhnert","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coph.2019.03.003_bib0250","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(17)32299-7","article-title":"Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial","volume":"390","author":"Gallant","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2019.03.003_bib0255","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1016\/S2352-3018(17)30016-4","article-title":"Bictegravir versus dolutegravir, each with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection: a randomised, double-blind, phase 2 trial","volume":"4","author":"Sax","year":"2017","journal-title":"Lancet HIV"},{"key":"10.1016\/j.coph.2019.03.003_bib0260","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(17)32340-1","volume":"390","author":"Sax","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2019.03.003_sbref0265","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1473-3099(19)30036-2","article-title":"Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial","volume":"19","author":"Aboud","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coph.2019.03.003_bib0270","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/QAD.0000000000001494","article-title":"Emergent drug resistance with integrase strand transfer inhibitor-based regimens","volume":"31","author":"Lepik","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.coph.2019.03.003_bib0275","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/S2352-3018(15)00027-2","article-title":"FLAMINGO study team: once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study","volume":"2","author":"Molina","year":"2015","journal-title":"Lancet HIV"},{"key":"10.1016\/j.coph.2019.03.003_bib0280","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1473-3099(13)70257-3","article-title":"Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial","volume":"13","author":"Raffi","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coph.2019.03.003_bib0285","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(12)61853-4","article-title":"Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study","volume":"381","author":"Raffi","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2019.03.003_bib0290","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/QAI.0000000000000790","article-title":"Brief report: dolutegravir plus Abacavir\/Lamivudine for the treatment of HIV-1 infection in antiretroviral therapy-naive patients: week 96 and week 144 results from the SINGLE randomized clinical trial","volume":"70","author":"Walmsley","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.coph.2019.03.003_bib0295","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00157-17","article-title":"The R263K dolutegravir resistance-associated substitution progressively decreases HIV-1 integration","volume":"8","author":"Mesplede","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.coph.2019.03.003_bib0300","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/infdis\/jiy175","article-title":"The s230r integrase substitution associated with virus load rebound during dolutegravir monotherapy confers low-level resistance to integrase strand-transfer inhibitors","volume":"218","author":"Pham","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coph.2019.03.003_bib0305","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1128\/JVI.06591-11","article-title":"Characterization of the R263K mutation in HIV-1 integrase that confers low-level resistance to the second-generation integrase strand transfer inhibitor dolutegravir","volume":"86","author":"Quashie","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coph.2019.03.003_sbref0310","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/jac\/dkx118","article-title":"HIV-1 strains belonging to large phylogenetic clusters show accelerated escape from integrase inhibitors in cell culture compared with viral isolates from singleton\/small clusters","volume":"72","author":"Brenner","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.coph.2019.03.003_sbref0315","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00922-17","article-title":"Mutations located outside the integrase gene can confer resistance to HIV-1 integrase strand transfer inhibitors","volume":"8","author":"Malet","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.coph.2019.03.003_sbref0320","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/infdis\/jiy176","article-title":"HIV-1 resistance dynamics in patients with virologic failure to dolutegravir maintenance monotherapy","volume":"218","author":"Wijting","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coph.2019.03.003_bib0325","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/molbev\/msw206","article-title":"Epistasis and pleiotropy affect the modularity of the genotype-phenotype map of cross-resistance in HIV-1","volume":"33","author":"Polster","year":"2016","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.coph.2019.03.003_bib0330","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/molbev\/msx095","article-title":"Inference of epistatic effects leading to entrenchment and drug resistance in HIV-1 protease","volume":"34","author":"Flynn","year":"2017","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.coph.2019.03.003_bib0335","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/ng.795","article-title":"A systems analysis of mutational effects in HIV-1 protease and reverse transcriptase","volume":"43","author":"Hinkley","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.coph.2019.03.003_bib0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163746","article-title":"Genome-wide association study of hiv whole genome sequences validated using drug resistance","volume":"11","author":"Power","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2019.03.003_bib0345","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1128\/JVI.03353-14","article-title":"Differential effects of the G118R, H51Y, and E138K resistance substitutions in different subtypes of HIV integrase","volume":"89","author":"Quashie","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coph.2019.03.003_bib0350","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciy1048","article-title":"Determining the origins of HIV-1 drug-resistant minority variants in people who are recently infected using phylogenetic reconstruction","author":"Mbisa","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coph.2019.03.003_bib0355","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/QAD.0000000000002105","article-title":"Caution is needed in interpreting HIV transmission chains by ultra-deep sequencing","volume":"33","author":"Todesco","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.coph.2019.03.003_bib0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002537","article-title":"Transmission of HIV-1 drug resistance mutations within partner-pairs: a cross-sectional study of a primary HIV infection cohort","volume":"15","author":"Stekler","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.coph.2019.03.003_bib0365","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00769-17","article-title":"No substantial evidence for sexual transmission of minority HIV drug resistance mutations in men who have sex with men","volume":"91","author":"Chaillon","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coph.2019.03.003_sbref0370","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1473-3099(18)30647-9","article-title":"WHO-UNAIDS network for HIV isolation characterisation: global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis","volume":"19","author":"Hemelaar","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coph.2019.03.003_bib0375","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1093\/molbev\/msh196","article-title":"A robust measure of HIV-1 population turnover within chronically infected individuals","volume":"21","author":"Achaz","year":"2004","journal-title":"Mol Biol Evol"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489218301061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489218301061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:48:57Z","timestamp":1761461337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489218301061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":75,"alternative-id":["S1471489218301061"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2019.03.003","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phylogenies in ART: HIV reservoirs, HIV latency and drug resistance","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2019.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}